TrialCancer biology & therapy2013

Single agent panitumumab in KRAS wild-type metastatic colorectal cancer patients following cetuximab-based regimens: Clinical outcome and biomarkers of efficacy.

Filippo Pietrantonio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.